Infrared Physics & Technology
Издатель: Elsevier · ISSN 1350-4495 · 100 статей
-
Modulating macrophage efferocytosis: Drug delivery strategies for enhancement, mimicry, and inhibition
Publication date: October 2026 Source: Acta Pharmaceutica Sinica B, Volume 16, Issue 10 Author(s): Zhihua Liu, Jiahui Wu, Jiayan Lyu, Zhou Zhou, Yuan Huang
-
Association between the use of traditional Chinese medicine patterns as an inclusion criterion and statistical significance in primary outcomes of randomized placebo-controlled trials of Chinese herbal formulas
Publication date: October 2026 Source: Acta Pharmaceutica Sinica B, Volume 16, Issue 10 Author(s): Zhijun Bu, Meirong Song, Chen Chen, Xinyi Shi, Xuefeng Wang, Yao Li, Jinchen Chong, Yijia Zhu, Feng Jiang, Yugen Chen
-
Antihypertensive drug-induced liver injury is rare, but strongly associated with HLA-B∗35:01
Publication date: October 2026 Source: Acta Pharmaceutica Sinica B, Volume 16, Issue 10 Author(s): Lily Dara, Paola Nicoletti, Chaudry Nasir Majeed, Andrew Dellinger, David E. Kleiner, Mahmoud G. Mohamed, Tatyana Kushner, Raj...
-
Reprogramming gut microbiota and targeting CXCL1: The multifaceted mechanism of PLP1 in ameliorating alcohol-induced liver disease
Publication date: October 2026 Source: Acta Pharmaceutica Sinica B, Volume 16, Issue 10 Author(s): Zhu Yang, Qiuyue Lv, Qiangbao Xu, Yan Chen, Yiping Yang, Zihan Li, Hui Che, Guodong Wang, Wei Wei, Jiangping Wu, Jun Han
-
Molecular mechanisms of YZG-331 ameliorated insomnia based on the gut microbiota–drug interaction
Publication date: October 2026 Source: Acta Pharmaceutica Sinica B, Volume 16, Issue 10 Author(s): Hengtong Zuo, Qinglan Guo, Bin Zhao, Jinyue Lu, Ru Feng, Jingyue Wang, Jianye Song, Jingyu Jin, Jiachun Hu, Yi Zhao, Hui Xu, Tiefeng...
-
BD2-selective BRD4 inhibitor ZX29 mitigates myocardial ischemia–reperfusion injury via BRD4–YY1–NCOA4 axis disruption and ferroptosis inhibition
Publication date: October 2026 Source: Acta Pharmaceutica Sinica B, Volume 16, Issue 10 Author(s): Zeyu Li, Meixiu Xin, Zhongkai Wu, Jing Lu, Ou Hu, Yong Zou, Peiqing Liu
-
A mechanistic quantitative systems pharmacology framework enriched by multiscale data enables model-informed translational development of mesenchymal stem cell therapy in lupus nephritis
Publication date: October 2026 Source: Acta Pharmaceutica Sinica B, Volume 16, Issue 10 Author(s): Sujie Zhang, Qixiang Zhang, Dandan Wang, Zichun Li, Xia Xiao, Qi Rao, Siyuan Yang, Yuchen Qu, Yiyang Xu, Ning Wei, Jing Wang, Yuan Gao,...
-
Therapeutic targeting of the PRMT6/FOXK1 axis restores lipid homeostasis and ameliorates hepatic steatosis and steatohepatitis in mice
Publication date: October 2026 Source: Acta Pharmaceutica Sinica B, Volume 16, Issue 10 Author(s): Yang Sun, Tao Chen, Lei Zhang, Jinlin Duan, Junyan Xue, Wentao Huang, Jianzhong Di, Yonglong Zhang
-
Identification and characterization of a non-nucleotide RdRp allosteric inhibitor with pan-coronavirus protection
Publication date: October 2026 Source: Acta Pharmaceutica Sinica B, Volume 16, Issue 10 Author(s): Qian Guo, Xiaomeng Yang, Zhihao Zhao, Jian-Piao Cai, Liang Wei, Kaiming Tang, Wan-Mui Chan, Allen Wing-Ho Chu, Yixin Huang, Tong-Yun...
-
Unnatural amino acid-based miniPROTACs enable efficient oncoprotein degradation
Publication date: October 2026 Source: Acta Pharmaceutica Sinica B, Volume 16, Issue 10 Author(s): Jianchao Zhang, Xiao Chen, Congli Chen, Fengming Li, Kefan Liao, Xiaoxiao Song, Ya Zeng, Jie Wang, Ming-Yuan Su, Chris Soon Heng Tan,...
-
Discovery of a small molecule RIOK1 inhibitor CINS-1 against colorectal cancer via disrupting ribosomal biosynthesis
Publication date: October 2026 Source: Acta Pharmaceutica Sinica B, Volume 16, Issue 10 Author(s): Ying Jiang, Chuan Huang, Fang Wu, Guolong Liu, Shanhe Wan, Yongxin Chen, Ruohong Yan, Zichao Yang, Yuanxin Tian, Tingting Zhang, Xiaoyun...
-
Machine learning-driven discovery of aniline phenylacetate derivatives as LasR-targeted biofilm inhibitors against Pseudomonas aeruginosa infections
Publication date: October 2026 Source: Acta Pharmaceutica Sinica B, Volume 16, Issue 10 Author(s): Yujing Huang, Haoming Chen, Jiamin Wu, Xiaojie Huang, Yingxin Zhang, Anmin Ren, Xiao Wu, Chengyin Huang, Wenguan Xie, Duntao Zu, Congzhen...
-
Identification of FDA-approved IMPDH inhibitors boosting the broad-spectrum antiviral potential of ribavirin through depleting cellular GTP pool
Publication date: October 2026 Source: Acta Pharmaceutica Sinica B, Volume 16, Issue 10 Author(s): Qiangyun Ai, Huina Hu, Kaixiong Ma, Qingxing Wang, Shenglin Huang, Yongzhi Lu, Nan Qi, Jinsai Shang, Ruikun Du, Shaobo Wang
-
Discovery of a potent covalent inhibitor for the treatment of sepsis targeting DNAJC9: Identification of a druggable target for inflammation
Publication date: October 2026 Source: Acta Pharmaceutica Sinica B, Volume 16, Issue 10 Author(s): Xingjun Li, Tao Yang, Hui Huang, Yalan Ma, Lu Liu, Qingqing Li, Naixia Zhang, Zhizhen Hui, Yazhou Li, Fang Bai, Qiangqiang Chen, Jiang...
-
In vivo validation of intramolecular bivalent glues targeting PSMA reveals potent and tissue-selective BRD4 degradation in prostate cancer
Publication date: October 2026 Source: Acta Pharmaceutica Sinica B, Volume 16, Issue 10 Author(s): Deqin Cai, Chunrong Li, Malick Bio Idrissou, Nina J. Hawkins, Ramesh Mudududdla, Xuankun Chen, Thao-Vy T. Nguyen, Xiaolei Li, Reinier...
-
Oral artificial microbio-vaccine triggers synergistic immunogenic cell death induction and tumor microenvironment remodeling for liver cancer therapy
Publication date: October 2026 Source: Acta Pharmaceutica Sinica B, Volume 16, Issue 10 Author(s): Qian Cheng, Siyao Li, Lu Deng, Li Xiong, Huiling Hu, Jingjing Li, Lele Zhang, Boda Guo, Chuan Zheng, Jinming Zhang
-
Stimulate-and-retain hydrogel strategy integrating oncolytic virus and oxaliplatin for dual ICD-inducing antitumor immunity
Publication date: October 2026 Source: Acta Pharmaceutica Sinica B, Volume 16, Issue 10 Author(s): Dan Zhang, Anxian Chen, Haimeng Huang, Wenjing Li, Qili Huang, Hongzhong Chen, Jiaxing Zhang, Li Yang, Caijun Sun, Xiaowei Zeng
-
Double coordination-driven Fe–DOX synergy enhances ferroptosis and immunogenic cancer therapy
Publication date: October 2026 Source: Acta Pharmaceutica Sinica B, Volume 16, Issue 10 Author(s): Gaeun Ma, Yun-Hwa Jeong, Yeonsu Ryu, Jae-Hyeon Lee, Seong-Bin Yang, Byeong-Kook Hwang, Jeong Uk Choi, Jooho Park
-
Remodeling macrophage efferocytosis and phenotype via targeted nanoimmunotherapy for atherosclerosis
Publication date: October 2026 Source: Acta Pharmaceutica Sinica B, Volume 16, Issue 10 Author(s): Zhongshan He, Yaoyao Luo, Yongjiang Li, Shuping Yang, Yingjun Fan, Yi Zhang, Shengbin Liu, Zhuoming Zhou, Chengjian Cao, Haixing Shi,...
-
Effects of anti-PEG antibodies on extravascular transport of stealth liposome: A study on interspecies differences
Publication date: October 2026 Source: Acta Pharmaceutica Sinica B, Volume 16, Issue 10 Author(s): Ercan Wu, Tianhao Ding, Yifei Yu, Mengyuan Liu, Jun Qian, Changyou Zhan
-
In vivo fate mapping of a paclitaxel-loaded polymeric micelle and its components
Publication date: October 2026 Source: Acta Pharmaceutica Sinica B, Volume 16, Issue 10 Author(s): Luyao Yu, Yingxia Guo, Tonghe Liu, Yunlong Sheng, Meichen Liu, Ning Zhang, Jiye Tian, Chunpeng Feng, Meiyun Shi, Lei Yin
-
Lysosomal membrane damage repair and acidification impairment restoration triggered by smart lipid nanoparticles for Alzheimer's disease treatment
Publication date: October 2026 Source: Acta Pharmaceutica Sinica B, Volume 16, Issue 10 Author(s): Jiaqing Yin, Wei Lv, Wei Zhao, Zhenwei Ding, Fei Zhu, Hongli Liu, Shengnan Li, Xiang Cao, Linfeng Liu, Kefan Song, Yue Gong, Jiangna Xu,...
-
The role of cardiomyocytic FOXP3 and extracellular vesicle-mediated delivery of FOXP3 into cardiomyocytes for treating pathological cardiac hypertrophy
Publication date: October 2026 Source: Acta Pharmaceutica Sinica B, Volume 16, Issue 10 Author(s): Jiahui Hong, Ping Tan, Yao Yuan, Zikun Lin, Wenjun Shan, Ya Liu, Haigang Zhang
-
Ultra-sensitive detection of receptor binding domain of SARS-CoV-2 based on artificial intelligence assisted antibody selection and antibody‒nucleic acid conjugation signal amplification
Publication date: October 2026 Source: Acta Pharmaceutica Sinica B, Volume 16, Issue 10 Author(s): Jiatong Liu, Wenfan Chen, Xiufeng Li, Yuanyuan Luo, Qiaomin Li, Wenbin Zhao, Qiaojun He, Su Zeng, Zhan Zhou, Sheng Cai
-
Learn from nature, surpass nature: Bionic immune cell engineering—A new paradigm for unlocking the dual “delivery-activation” code in cancer therapy
Publication date: October 2026 Source: Acta Pharmaceutica Sinica B, Volume 16, Issue 10 Author(s): Guanyi Chen, Baohu Li, Shenghua Gao, Jinfei Yang, Peng Zhan
-
miniPROTACs: Bridging PROTACs and molecular glues with a new degron alphabet
Publication date: October 2026 Source: Acta Pharmaceutica Sinica B, Volume 16, Issue 10 Author(s): Jin Wang
-
Illuminating the black box: Mapping the fates of polymeric micelle drug carriers in vivo
Publication date: October 2026 Source: Acta Pharmaceutica Sinica B, Volume 16, Issue 10 Author(s): Xinxin Ding
-
Author correction to “Hollow copper sulfide nanoparticles carrying ISRIB for the sensitized photothermal therapy of breast cancer and brain metastases through inhibiting stress granule formation and reprogramming tumor-associated macrophages” [Acta Pharmaceutica Sinica B 13 (2023) 3471–3488]
Publication date: October 2026 Source: Acta Pharmaceutica Sinica B, Volume 16, Issue 10 Author(s): Fan Tong, Haili Hu, Yanyan Xu, Yang Zhou, Rou Xie, Ting Lei, Yufan Du, Wenqin Yang, Siqin He, Yuan Huang, Tao Gong, Huile Gao
-
Author correction to “Chemical screen identifies shikonin as a broad DNA damage response inhibitor that enhances chemotherapy through inhibiting ATM and ATR” [Acta Pharm Sin B 12 (2022) 1339–1350]
Publication date: October 2026 Source: Acta Pharmaceutica Sinica B, Volume 16, Issue 10 Author(s): Fangfang Wang, Sora Jin, Franklin Mayca Pozo, Danmei Tian, Xiyang Tang, Yi Dai, Xinsheng Yao, Jinshan Tang, Youwei Zhang
-
The development of orally active peptides: Prioritizing drug-likeness or bioactivity?
Publication date: Available online 29 October 2026 Source: Acta Pharmaceutica Sinica B Author(s): Sanhu Gou, Zufang Ba, Bingqian Ren, Hui Liu, Yun Zhang, Chao Zhong, Yongxi Dong, Jingman Ni